Detalhe da pesquisa
1.
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.
Gastroenterology
; 161(4): 1270-1287.e19, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224738
2.
NLRP6 Deficiency in CD4 T Cells Decreases T Cell Survival Associated with Increased Cell Death.
J Immunol
; 203(2): 544-556, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152078
3.
Small but powerful: will nanoparticles be the future state-of-the-art therapy for IBD?
Expert Opin Drug Deliv
; 19(3): 235-245, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184617
4.
Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging.
Inflamm Bowel Dis
; 28(11): 1637-1646, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699622
5.
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.
J Mol Med (Berl)
; 98(10): 1385-1395, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808093
6.
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation.
J Crohns Colitis
; 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808031